European Archives - Page 1410 of 1432 - European Medical Journal

Chronic Renal Allograft Dysfunction Antibody-Mediated: An Update

This paper reviews the most important studies on chronic antibody-mediated rejection (cABMR), which is an important cause of late graft dysfunction after…

Pregnancy in Systemic Lupus Erythematosus Patients with Nephritis

Pregnancy in patients with lupus nephritis is a challenging clinical situation. Although not absolutely contraindicated, it is associated with increased…

The Use of Vaptans in Hyponatraemia

Hyponatraemia is the most common electrolyte disorder in clinical practice. It is associated with increased morbidity, mortality, and length of hospital…

Cardiovascular Remodelling In Chronic Kidney Disease

Left ventricular (LV) structure and function abnormalities are frequent in patients with chronic uraemia; these disorders increase the risk of…

EMJ Nephrology 2014

I would like to welcome you all to this second edition of the European Medical Journal – Nephrology. Whatever stage you are at in your career, this…

EMJ

Taking B Vitamins Won’t Prevent Alzheimer’s Disease

Taking B vitamins doesn’t slow mental decline as we age, nor is it likely to prevent Alzheimer’s disease, conclude Oxford University researchers…

EMJ

WFN launches first World Brain Day on 22 July

n 22 July, the World Federation of Neurology (WFN) launches the first “World Brain Day,” an event dedicated to bringing more attention to the importance…

Autosomal Dominant Polycystic Kidney Disease: What Do We Need To Know For Counselling?

In the new millennium, few kidney diseases changed their perspectives as much as autosomal dominant polycystic kidney disease (ADPKD). New diagnostic…

Apomorphine Penject – Emerging Evidence and Treatment Strategies for Delayed on and off Periods in Parkinson’s disease

This educational symposium was held during the Joint Congress of European Neurology (EFNS–ENS), which took place from 31st May to 3rd June 2014 in…

The Evolving Ms Landscape: Challenges and Opportunities

Historically, multiple sclerosis (MS) treatment goals have focused on clinical endpoints, delaying disability, and reducing relapse frequency, and…